Managing Information as a Strategic Asset in Life Sciences

Author:

Lynette Ferrara, Dan Foltz, Fran Turisco

The pharmaceutical / life sciences industry is inherently a risky business. Escalating costs, more stringent requirements for new medication approval and adoption, and revenue pressures will require major changes in its operating model. The challenge to do more with less will require doing it differently. An important component to addressing the challenge is the ability to manage information as a strategic asset to create value. Timely access to rich internal and external sources of scientific, patient care and healthcare cost information is increasingly critical.

A health intelligence program provides the technical platform in addition to the processes, governance and data management to successfully move from study-focused data to enterprise clinical and research information management.

Download "Managing Information as a Strategic Asset in Life Sciences" (PDF, 222KB)

For more information, please contact us.